These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

16 related articles for article (PubMed ID: 25176268)

  • 1. [THE INFLUENCE OF CYTOFLAVIN AND CARDIOXIPIN ON THE PARAMETERS OF 24-HOUR ARTERIAL PRESSURE MONITORING IN PATIENTS WITH CHRONIC CEREBRAL CIRCULATION INSUFFICIENCY, ARTERIAL HYPERTENSION AND HYPERCHOLESTEROLEMIA].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Klin Med (Mosk); 2015; 93(2):67-71. PubMed ID: 26117922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The influence of cytoflavin and cardioxipin on the indices of lipid peroxidation and antioxidant protection in the blood of rat with dyslipidemia].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Eksp Klin Farmakol; 2014; 77(6):27-9. PubMed ID: 25102732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Experimental study on cytoflavin pharmacological correction of cyclophosphamide-induced toxic affections of the liver and kidneys].
    Kashuro VA; Glushkov SI; Minaeva LV; Novikova TM
    Antibiot Khimioter; 2010; 55(9-10):29-32. PubMed ID: 21400751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection].
    Isakov VA; Kovalenko AL; Turkin VV; Makarov VI
    Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy].
    Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP
    Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The assessment of the effects of cytoflavin and cardioxipin on the emotional status of rats with dyslipidemia].
    Vodop'ianova OA; Moiseeva IIa; Rodina OP; Kustikova IN; Antropova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):53-5. PubMed ID: 25176268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenetic correction of metabolic disturbances in chronic liver affections].
    Romantsov MG; Petrov AIu; Aleksandrova LN; Sukhanov DS; Kovalenko AL
    Antibiot Khimioter; 2012; 57(11-12):33-41. PubMed ID: 23700935
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.